Liz Pfeifer said she felt tremendously overwhelmed when she was diagnosed with breast cancer. Having breast cancer made her feel like she was losing her identity and her ability to cope. But then, as she progressed through treatment and gathered ...

Oregon Health & Science University is one of a select group of internationally regarded institutions that have been invited to build and operate satellite research facilities entirely funded by, and based in, the state of Florida. The Scripps Research ...

A research team led by scientists at the University of Minnesota Medical School and Oregon Health & Science University have outlined the challenges and made suggestions on how to advance research and improve treatments for brain disorders. The review ...

Researchers at Oregon Health & Science University’s Neurological Sciences Institute have uncovered the system that tells the body when to perform one of its most basic defenses against the cold: shivering. The scientists have discovered the brain’s ...

Researchers at Oregon Health & Science University have uncovered new information about the body’s immune system in a study that suggests new strategies may be in order for protecting the country’s aging population against disease. The research is ...

An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer. Researchers working with the cancer mutation in the ...

Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia. “Data at this weekend’s ...

Oregon Health & Science University Cancer Institute researchers have found a new, experimental drug candidate it to be effective against a highly resistant mutation in chronic myeloid leukemia (CML). This drug candidate could build on the legacy of ...

Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days. This ...

Oregon Health & Science University Cancer Institute researchers Jeff Tyner, Ph.D., postdoctoral fellow in hematology/medical oncology and Bill Chang, M.D., Ph.D., assistant professor of pediatric hematology and oncology, OHSU School of Medicine, have ...